Open a Free Demat Account !
₹0 AMC, ₹20 Flat Brokerage
Neuland Lab
NSE: NEULANDLAB
Healthcare
₹23800.00605.002.61%(1D)
Performance Stats for Neuland Lab
Day Range
Low: ₹23235.00
High: ₹24150.00
52 Week Range
Low: ₹11500.00
High: ₹24225.00
Open Price
23265.00Previous Close
23195.00Volume
55256.00Open Price
23265.00Previous Close
23195.00Volume
55256.00Fundamentals of Neuland Lab
ROCE
26.5%
EPS
₹387.19
Dividend Yield
0.28%
P/E Ratio
42.68
P/B Ratio
8.31
Debt to Equity
0.14
Current Ratio
1.88
Sales Growth
78.33%
Profit Growth
184.20%
EBIT Growth
186.10%
Financials of Neuland Lab
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Neuland Lab
About Neuland Lab
Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao. The Company is engaged in manufacturing and selling of bulk drugs such as Salbutamol Sulphate, Terbutaline Sulphate, Labetalol Hydrochloride and ...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarey Drugs And Pharm | ₹94.99 4.99% |
| Aarti Drugs | ₹437 3.2% |
| Aarti Pharmalabs | ₹829 0.08% |
| Abbott India | ₹25230 0.02% |
Most Viewed Stocks
Sorry, option data not Found For this Stock :(
Events Related to Neuland Lab
Board Meeting
Aug 5, 2026
AGM
Aug 4, 2026
Dividend
Jul 24, 2026
Board Meeting
May 12, 2026
Board Meeting
Feb 9, 2026
News About Neuland Lab
Vijay Kedia Portfolio: 5 stocks surge up to 55% in CY26; 1 new addition in June quarter
Aug 22, 2026
Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit
Aug 6, 2026
Neuland Laboratories Stock Surges 7% After Q1 Profit Swells 10-Fold
Aug 6, 2026
NDTV Profit Business Leadership Awards 2026: BSE Wins Wealth Creator Of The Year
Jul 26, 2026
Goldman Sachs Retains "Buy" On Neuland Labs After Q4 Performance Exceeds Estimates, Hikes Target Price
May 13, 2026
